HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gary L Robertson Selected Research

Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)

8/2005Expression of three different mutations in the arginine vasopressin gene suggests genotype-phenotype correlation in familial neurohypophyseal diabetes insipidus kindreds.
9/2004Differential cellular handling of defective arginine vasopressin (AVP) prohormones in cells expressing mutations of the AVP gene associated with autosomal dominant and recessive familial neurohypophyseal diabetes insipidus.
1/2004Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis.
1/2004Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus.
7/2002Autosomal dominant neurohypophyseal diabetes insipidus due to substitution of histidine for tyrosine(2) in the vasopressin moiety of the hormone precursor.
5/2002Clinical and molecular analysis of three families with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel and recurrent mutations in the vasopressin-neurophysin II gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gary L Robertson Research Topics

Disease

6Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)
08/2005 - 05/2002
2Diabetes Insipidus
01/2022 - 07/2011
2Psychogenic Polydipsia
01/2021 - 01/2016
2Nephrogenic Diabetes Insipidus
07/2011 - 06/2000
2Hyponatremia
03/2011 - 07/2006
1Polyuria
10/2013
1Inappropriate ADH Syndrome (SIADH)
03/2011
1Heart Failure
03/2011
1Hypovolemia
03/2011
1End Stage Liver Disease
03/2011
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
07/2006
1Renal Insufficiency (Renal Failure)
07/2006
1Wounds and Injuries (Trauma)
07/2006
1Rare Diseases (Rare Disease)
06/2000

Drug/Important Bio-Agent (IBA)

8Vasopressins (Vasopressin)IBA
01/2022 - 05/2002
8Arginine Vasopressin (Argipressin)IBA
01/2021 - 01/2004
2Antidiuretic AgentsIBA
01/2016 - 07/2011
2Neurophysins (Neurophysin I)IBA
07/2002 - 05/2002
1Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
01/2022
1Cystinyl AminopeptidaseIBA
01/2021
1EnzymesIBA
01/2016
1TabletsIBA
10/2013
1Aquaporin 2IBA
07/2011
1Aquaporins (Water Channels)IBA
07/2011
1DiureticsIBA
03/2011
1Pharmaceutical PreparationsIBA
03/2011
1SodiumIBA
07/2006
1Histidine (L-Histidine)FDA Link
07/2002
1Hormones (Hormone)IBA
07/2002
1Tyrosine (L-Tyrosine)FDA Link
07/2002
1Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
06/2000

Therapy/Procedure

2Therapeutics
01/2022 - 03/2011